Tag Archives: Analysis

Forbes’ Emily Willingham Pretends CDC Study Results Don’t Exist

cdcabstracts

Editor’s Note: Click the above image to enlarge.

By Jake Crosby

Forbes’ writers seem to have trouble reading scientific abstracts. In December, its senior editor Matthew Herper cited a press release that contradicted the research he discussed to endorse the vaccine efficacy of Gardasil. That, however, pales in comparison to the type of misrepresentation contributor Emily Willingham made when she conflated an earlier, suppressed CDC analysis (left abstract in image) showing thimerosal is associated with autism with a later, watered-down analysis CDC distributed at a public meeting that showed no association (right abstract in image). All the more remarkable is that she is an autism parent herself and has a PhD in biology.

Following the press release by Focus Autism, AutismOne and A Shot of Truth about the earlier abstract uncovered by A Shot of Truth scientific advisor Dr. Brian Hooker, Willingham responded with a long and verbose article titled, “Is The CDC Hiding Data About Mercury, Vaccines, and Autism?” She then answered her own title with: “You know the rule. The answer is, ‘No.'”

One paragraph in, she was already getting basic facts of the abstract disastrously wrong: “In 1999, four authors affiliated with the CDC presented an abstract at a conference … a CDC conference for fellows of its Epidemic Intelligence Service (EIS).” The conference takes place annually in April, but the research project of thimerosal did not even begin until August of that year as pointed out by chemist and Coalition for Mercury-Free Drugs‘ secretary Dr. Paul King in a comment to me. That error of Willingham’s, however, could hardly have predicted what was to come.

Although she never linked to the abstract from her article, she did read it and quoted directly from it – noting that it compared a “highest exposure group” to an “unexposed group”. Though she acknowledged the study authors “reported an increased risk for nondegenerative neurological disorders,” she never acknowledged they included autism.

Then five paragraphs into her article she suddenly switched from talking about the long-suppressed abstract to talking about a later analysis  where no comparison of autism across highest-and-unexposed groups was included. The manuscript describing that analysis, dated June 1st, 2000, was presented at the closed Simpsonwood meeting of federal officials and pharmaceutical industry representatives the following week and then distributed by CDC at a public meeting of the Advisory Committee on Immunization Practices later that same month. That document Willingham cited was not concealed from the public for over a decade and did not show that thimerosal is associated with autism, unlike the abstract of the earlier analysis. Yet she spent the rest of her article discussing the later study as if it was the same CDC study cited in the press release circulated by Focus Autism, AutismOne and A Shot of Truth and later picked up by Health Impact News Daily whose headline she drew attention to.

She even quoted the lead investigator Dr. Thomas Verstraeten presenting the lack of association with autism in the later manuscript:

“This is the result for autism, in which we don’t see much of a trend except for a slight, but not significant, increase for the highest exposure. The overall test for trend is statistically not significant.”

Dr. Verstraeten was under considerable pressure to reanalyze the data to  make the association between thimerosal and neurological disorders disappear, as evidenced in an email he titled “It just won’t go away.”  He wrote “…some of the RRs [relative risks] increase over the categories and I haven’t yet found an alternative explanation… Please let me know if you can think of one.” He and his colleagues issued successive studies  watering down the original results and ultimately, as  Willingham conceded, he was hired by vaccine maker GlaxoSmithKline.

What Willingham never quoted, however, was the reported result for autism in the abstract of the earlier analysis that the press release was actually about:

“The relative risk (RR) of developing a neurologic development disorders was 1.8 (95% confidence intervals [CI] = 1.1-2.8) when comparing the highest exposure group at 1 month of age (cumulative dose  > 25 ug) to the unexposed group. Within this group we also found an elevated risk for the following disorders: autism (RR 7.6, 95% CI = 1.8-31.5), nonorganic sleep disorders (RR 5.0, 95% CI = 1.6-15.9), and speech disorders (RR 2.1, 95% CI=1.1-4.0).”

Apparently, Willingham is imitating CDC, as all the way back in 2004 one of the coauthors of both CDC analyses Dr. Frank DeStefano said in a presentation to the Institute of Medicine (IOM) that:

“In no analyses were significant increased risks found for ADD or autism”

In that same presentation, DeStefano also claimed the “Initial” analysis was a study dated February, 29th, 2000, where the association with autism originally reported in the suppressed abstract was apparently diluted away by combining the highest exposure category with a lower exposure category. The very existence of the positive research results from the long-suppressed study abstract was denied.

One decade later and Emily Willingham and Forbes Magazine are now following CDC’s lead, as are other vaccine industry talking heads.

Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.

Mark Blaxill to Omnibus Attorneys: “how deeply f*cked up the world is when the Geiers are considered credible analysts and I am not.”

blaxillongeiers

By Jake Crosby

Click the above screenshot to enlarge the July 2007 email where then-Vice President of SafeMinds Mark Blaxill stated in email to omnibus autism proceeding attorneys Mike Williams and Tom Powers concerning petitioners’ expert witnesses Dr. Mark and David Geier:

“I hope you understand how deeply fucked up the world is when the Geiers are considered credible analysts and I am not.”

Blaxill succeeded in turning Williams against his own expert witnesses, as Williams responded: “I do understand”.

Autism Investigated has acquired this latest installment of troubling emails about the Geiers between Blaxill and Williams from a source that wishes to remain anonymous. Last October, Autism Investigated posted emails dated 2003-2004 in which Mark Blaxill disparaged expert witnesses Dr. Mark and David Geier to Mike Williams – saying the Geiers “can do our cause more harm than good,” calling their work “sloppy” and claiming he could “rip [their work] to shreds.” Those emails were also obtained from a confidential source. (See mercury toxicity expert Dr. Boyd Haley’s response to Blaxill’s claim.)

The long email from Mike Williams to which Blaxill was responding can be seen in the following screenshot and was addressed to Lyn Redwood, President of SafeMinds (now Vice President of SafeMinds). Copied on the email in addition to Blaxill were Tom Powers and SafeMinds’ then-Executive Director (now President) Sallie Bernard. Note also that Williams described pursuit of “experts other than Mark Geier” before lamenting, “if only Mark Blaxill had an MPH or equivalent.” (screenshot 1, click to enlarge)
fdup2

Further down in that email, Williams reveals how influenced he was by Blaxill, saying: “On the genetics issue, we need someone other than Mark Geier to say what Mark Blaxill and you all proved…” (screenshot 2, click to enlarge) Incredibly, Williams was persuaded that Dr. Geier, a geneticist, was incapable of speaking on the genetics issue even though his genetic research had won him presidential recognition. What’s more, his son David actually discovered results from CDC researcher Dr. Thomas Verstraeten’s epidemiological analyses of thimerosal exposure showing vastly increased risks for neurodevelopmental disorders including autism compared to those who weren’t exposed to thimerosal during the first month of life. That a seasoned attorney was so manipulated by Mark Blaxill should serve as a cautionary tale in light of current events.

fdup3
fdup4

Jake Crosby is editor of Autism Investigated and is diagnosed with an autism spectrum disorder. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.